{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:49:40Z","timestamp":1787060980841,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"TB Veteran Association"},{"DOI":"10.13039\/100015752","name":"British Columbia Lung Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015752","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institute of Health Research","doi-asserted-by":"crossref","award":["MOP-97898"],"award-info":[{"award-number":["MOP-97898"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.vaccine.2017.02.065","type":"journal-article","created":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T03:01:31Z","timestamp":1489719691000},"page":"2060-2068","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Expression of Cathepsin S in BCG converts it into a pro-apoptotic and highly immunogenic strain"],"prefix":"10.1016","volume":"35","author":[{"given":"Alice","family":"Lau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijender","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafid","family":"Soualhine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakaria","family":"Hmama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.02.065_b0005","unstructured":"World Health Organization. Tuberculosis fact sheet no. 104. March 2016; 2016."},{"issue":"5","key":"10.1016\/j.vaccine.2017.02.065_b0010","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nrd4001","article-title":"Advances in the development of new tuberculosis drugs and treatment regimens","volume":"12","author":"Zumla","year":"2013","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"10.1016\/j.vaccine.2017.02.065_b0015","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1371\/journal.pmed.0040238","article-title":"Patient adherence to tuberculosis treatment: a systematic review of qualitative research","volume":"4","author":"Munro","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2017.02.065_b0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2458-11-55","article-title":"Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study","volume":"11","author":"Tseng","year":"2011","journal-title":"BMC Public Health"},{"issue":"6","key":"10.1016\/j.vaccine.2017.02.065_b0025","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018523","article-title":"Novel vaccination strategies against tuberculosis","volume":"4","author":"Andersen","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.vaccine.2017.02.065_b0030","first-page":"567","article-title":"Protective inoculation against tuberculosis with BCG","volume":"19","author":"Calmette","year":"1929","journal-title":"Am Rev Tuberc"},{"issue":"6","key":"10.1016\/j.vaccine.2017.02.065_b0035","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/ije\/22.6.1154","article-title":"Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis","volume":"22","author":"Rodrigues","year":"1993","journal-title":"Int J Epidemiol"},{"issue":"9","key":"10.1016\/j.vaccine.2017.02.065_b0040","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2017.02.065_b0045","doi-asserted-by":"crossref","first-page":"S353","DOI":"10.1093\/clinids\/11.Supplement_2.S353","article-title":"The BCG story: lessons from the past and implications for the future","volume":"11","author":"Fine","year":"1989","journal-title":"Rev Infect Dis"},{"issue":"20","key":"10.1016\/j.vaccine.2017.02.065_b0050","doi-asserted-by":"crossref","first-page":"13326","DOI":"10.1074\/jbc.272.20.13326","article-title":"Arrest of mycobacterial phagosome maturation is caused by a block in vesicle fusion between stages controlled by rab5 and rab7","volume":"272","author":"Via","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2017.02.065_b0055","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1286-4579(01)01376-4","article-title":"Entry and survival of pathogenic mycobacteria in macrophages","volume":"3","author":"Pieters","year":"2001","journal-title":"Microb Infect"},{"issue":"7","key":"10.1016\/j.vaccine.2017.02.065_b0060","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1128\/IAI.72.7.4200-4209.2004","article-title":"Mycobacterium bovis BCG urease attenuates major histocompatibility complex class II trafficking to the macrophage cell surface","volume":"72","author":"Sendide","year":"2004","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2017.02.065_b0065","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1128\/IAI.72.4.2101-2110.2004","article-title":"Inhibition of major histocompatibility complex II expression and antigen processing in murine alveolar macrophages by Mycobacterium bovis BCG and the 19-kilodalton mycobacterial lipoprotein","volume":"72","author":"Fulton","year":"2004","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2017.02.065_b0070","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nm906","article-title":"Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis","volume":"9","author":"Schaible","year":"2003","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.vaccine.2017.02.065_b0075","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1086\/315676","article-title":"Mannosylated lipoarabinomannan antagonizes Mycobacterium tuberculosis-induced macrophage apoptosis by altering Ca2+-dependent cell signaling","volume":"182","author":"Rojas","year":"2000","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2017.02.065_b0080","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.vaccine.2017.02.065_b0085","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1128\/IAI.00004-07","article-title":"Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon","volume":"75","author":"Radosevic","year":"2007","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2017.02.065_b0090","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1164\/rccm.200910-1484OC","article-title":"The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults","volume":"181","author":"Abel","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.vaccine.2017.02.065_b0095","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.4049\/jimmunol.179.8.5137","article-title":"Mycobacterium bovis bacillus Calmette-Guerin secreting active cathepsin S stimulates expression of mature MHC class II molecules and antigen presentation in human macrophages","volume":"179","author":"Soualhine","year":"2007","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2017.02.065_b0100","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.4049\/jimmunol.175.8.5324","article-title":"Mycobacterium bovis BCG attenuates surface expression of mature class II molecules through IL-10-dependent inhibition of cathepsin S","volume":"175","author":"Sendide","year":"2005","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2017.02.065_b0105","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1074-7613(00)80249-6","article-title":"Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading","volume":"4","author":"Riese","year":"1996","journal-title":"Immunity"},{"issue":"27","key":"10.1016\/j.vaccine.2017.02.065_b0110","doi-asserted-by":"crossref","first-page":"19140","DOI":"10.1074\/jbc.M802513200","article-title":"Cysteine cathepsins trigger caspase-dependent cell death through cleavage of bid and antiapoptotic Bcl-2 homologues","volume":"283","author":"Droga-Mazovec","year":"2008","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.vaccine.2017.02.065_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3349\/ymj.2009.50.1.1","article-title":"Macrophage apoptosis in tuberculosis","volume":"50","author":"Lee","year":"2009","journal-title":"Yonsei Med J"},{"issue":"Pt3","key":"10.1016\/j.vaccine.2017.02.065_b0120","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1042\/bst0320496","article-title":"Macrophage apoptosis in host immunity to mycobacterial infections","volume":"32","author":"Fairbairn","year":"2004","journal-title":"Biochem Soc Trans"},{"issue":"12","key":"10.1016\/j.vaccine.2017.02.065_b0125","doi-asserted-by":"crossref","first-page":"e0145833","DOI":"10.1371\/journal.pone.0145833","article-title":"Improving the immunogenicity of the Mycobacterium bovis BCG vaccine by non-genetic bacterial surface decoration using the avidin-biotin system","volume":"10","author":"Liao","year":"2015","journal-title":"PLoS ONE"},{"issue":"18","key":"10.1016\/j.vaccine.2017.02.065_b0130","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1016\/j.vaccine.2007.01.087","article-title":"Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine","volume":"25","author":"Dennehy","year":"2007","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2017.02.065_b0135","doi-asserted-by":"crossref","first-page":"e9823","DOI":"10.1371\/journal.pone.0009823","article-title":"Sensitive detection of gene expression in mycobacteria under replicating and non-replicating conditions using optimized far-red reporters","volume":"5","author":"Carroll","year":"2010","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.vaccine.2017.02.065_b0140","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1054\/tube.2002.0374","article-title":"Expression of foreign genes in Mycobacterium bovis BCG strains using different promoters reveals instability of the hsp60 promoter for expression of foreign genes in Mycobacterium bovis BCG strains","volume":"82","author":"Al-Zarouni","year":"2002","journal-title":"Tuberculosis (Edinb)"},{"issue":"3","key":"10.1016\/j.vaccine.2017.02.065_b0145","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.plasmid.2009.07.003","article-title":"A broad-range of recombination cloning vectors in mycobacteria","volume":"62","author":"Sun","year":"2009","journal-title":"Plasmid"},{"issue":"4","key":"10.1016\/j.vaccine.2017.02.065_b0150","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1084\/jem.191.4.613","article-title":"Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells","volume":"191","author":"Yrlid","year":"2000","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.vaccine.2017.02.065_b0155","doi-asserted-by":"crossref","first-page":"8106","DOI":"10.4049\/jimmunol.174.12.8106","article-title":"Role of cathepsin S-dependent epithelial cell apoptosis in IFN-gamma-induced alveolar remodeling and pulmonary emphysema","volume":"174","author":"Zheng","year":"2005","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2017.02.065_b0160","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1128\/IAI.71.1.254-259.2003","article-title":"THP-1 cell apoptosis in response to Mycobacterial infection","volume":"71","author":"Riendeau","year":"2003","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2017.02.065_b0165","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1128\/IAI.67.9.4312-4319.1999","article-title":"Identification of amino acid residues of the T-cell epitope of Mycobacterium tuberculosis alpha antigen critical for Vbeta11(+) Th1 cells","volume":"67","author":"Kariyone","year":"1999","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2017.02.065_b0170","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/infdis\/jiu347","article-title":"Central memory CD4+ T cells are responsible for the recombinant Bacillus Calmette-Guerin DeltaureC::hly vaccine's superior protection against tuberculosis","volume":"210","author":"Vogelzang","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.065_b0175","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4614-6111-1_8","article-title":"Antigen-specific CD8(+) T cells and protective immunity to tuberculosis","volume":"783","author":"Behar","year":"2013","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"10.1016\/j.vaccine.2017.02.065_b0180","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1615\/CritRevImmunol.v26.i4.30","article-title":"Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity","volume":"26","author":"Woodworth","year":"2006","journal-title":"Crit Rev Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2017.02.065_b0185","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1189\/jlb.10.1189","article-title":"Mycobacterium bovis BCG disrupts the interaction of Rab7 with RILP contributing to inhibition of phagosome maturation","volume":"82","author":"Sun","year":"2007","journal-title":"J Leukoc Biol"},{"issue":"11","key":"10.1016\/j.vaccine.2017.02.065_b0190","doi-asserted-by":"crossref","first-page":"6664","DOI":"10.1073\/pnas.1131604100","article-title":"Human cathepsin S, but not cathepsin L, degrades efficiently MHC class II-associated invariant chain in nonprofessional APCs","volume":"100","author":"Bania","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.vaccine.2017.02.065_b0195","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1097-2765(04)00209-6","article-title":"A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP\/Cux transcription factor","volume":"14","author":"Goulet","year":"2004","journal-title":"Mol Cell"},{"issue":"8","key":"10.1016\/j.vaccine.2017.02.065_b0200","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nri3254","article-title":"Cross-presentation by dendritic cells","volume":"12","author":"Joffre","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2017.02.065_b0205","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1074\/jbc.M308347200","article-title":"Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins","volume":"279","author":"Cirman","year":"2004","journal-title":"J Biol Chem"},{"issue":"6403","key":"10.1016\/j.vaccine.2017.02.065_b0210","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/360474a0","article-title":"HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides","volume":"360","author":"Riberdy","year":"1992","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.vaccine.2017.02.065_b0215","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2017.02.065_b0220","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1600-065X.2008.00693.x","article-title":"Early T-cell responses in tuberculosis immunity","volume":"225","author":"Winslow","year":"2008","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2017.02.065_b0225","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4049\/jimmunol.165.1.353","article-title":"CD8+ CTL from lungs of Mycobacterium tuberculosis-infected mice express perforin in vivo and lyse infected macrophages","volume":"165","author":"Serbina","year":"2000","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2017.02.065_b0230","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20041690","article-title":"Cytolytic CD8+ T cells recognizing CFP10 are recruited to the lung after Mycobacterium tuberculosis infection","volume":"200","author":"Kamath","year":"2004","journal-title":"J Exp Med"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2017.02.065_b0235","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.micinf.2005.03.012","article-title":"Improved protection by recombinant BCG","volume":"7","author":"Nasser Eddine","year":"2005","journal-title":"Microbes Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2017.02.065_b0240","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4049\/jimmunol.166.1.447","article-title":"Lipoprotein access to MHC class I presentation during infection of murine macrophages with live mycobacteria","volume":"166","author":"Neyrolles","year":"2001","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2017.02.065_b0245","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.immuni.2004.07.004","article-title":"Important role of cathepsin S in generating peptides for TAP-independent MHC class I cross presentation in vivo","volume":"21","author":"Shen","year":"2004","journal-title":"Immunity"},{"issue":"33","key":"10.1016\/j.vaccine.2017.02.065_b0250","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1016\/j.vaccine.2009.05.048","article-title":"Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2017.02.065_b0255","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.it.2012.03.004","article-title":"Tuberculosis vaccine development: strength lies in tenacity","volume":"33","author":"Kaufmann","year":"2012","journal-title":"Trends Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2017.02.065_b0260","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1172\/JCI22953","article-title":"Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS","volume":"115","author":"Williams","year":"2005","journal-title":"J Clin Invest"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17302906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17302906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T21:24:01Z","timestamp":1601760241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17302906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":52,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0264410X17302906"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.065","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of Cathepsin S in BCG converts it into a pro-apoptotic and highly immunogenic strain","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2017 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}